Overview
Mansonelliasis encompasses infections caused by three species of nematodes within the Mansonella genus: Mansonella perstans, Mansonella ozzardi, and Mansonella streptocerca. These filarial infections are primarily found in tropical and subtropical regions, particularly in Africa, South America, and some parts of the Caribbean. The clinical manifestations of mansonelliasis are often subtle and can include pruritus, rash, inguinal adenopathy, and less commonly, more severe symptoms like giddiness or elephantiasis. Despite the presence of adult worms in various abdominal locations without causing overt symptoms, the microfilariae circulating in the blood or residing in tissues are responsible for the clinical presentation. Understanding the epidemiology, pathophysiology, and clinical features is crucial for accurate diagnosis and effective management, especially in endemic areas where multiple filarial infections may coexist.
Pathophysiology
The pathophysiology of mansonelliasis involves the complex life cycle of Mansonella species, which includes both human hosts and specific insect vectors. Adult worms of M. perstans have been identified in diverse abdominal locations such as hernial sacs, mesenteric lymph nodes, peripancreatic tissue, perirenal tissue, hepatic portal connective tissue, and serosal surfaces of the small intestine, as observed in nine patients [PMID:3688309]. Notably, these worm locations were not associated with clinical symptoms, suggesting that the presence of adult worms alone does not necessarily lead to overt disease. Instead, the clinical manifestations are primarily driven by the presence of microfilariae. Histological examinations have revealed that these microfilariae predominantly inhabit superficial capillary vessels rather than freely circulating in extravascular tissues [PMID:6969037]. This vascular dwelling likely contributes to the varied and often mild clinical symptoms observed, such as pruritus and rash, as the microfilariae can induce inflammatory responses within the microvasculature.
The lack of significant clinical symptoms despite the presence of adult worms underscores the importance of focusing on microfilariae in both diagnosis and management. The asymptomatic nature of adult worm locations highlights the need for vigilant monitoring of microfilarial loads and periodic assessments to detect any potential progression or complications. Understanding these pathophysiological nuances is essential for clinicians to interpret clinical findings accurately and tailor management strategies accordingly.
Epidemiology
Mansonelliasis exhibits distinct epidemiological patterns across different regions, influenced by factors such as age, gender, occupation, and geographic location. In Bauchi State, Nigeria, the prevalence of Mansonella streptocerca microfilariae was found to increase with host age, with significant differences noted between younger (below 31 years) and older individuals [PMID:7951395]. This age-related trend suggests a cumulative exposure effect over time, possibly due to prolonged vector contact.
A comprehensive survey in Abia and Imo States, Nigeria, between November 1988 and April 1991, revealed a 28.6% prevalence of M. perstans microfilariae, with notable disparities between rural (34.6%) and urban (22.5%) dwellers, as well as between males (30.8%) and females (26.3%) [PMID:1456469]. Occupational factors also played a role, with higher infection rates among farmers (59.8%) and palm wine tappers (46.1%) compared to civil servants (7.6%). These findings indicate that environmental and occupational exposures significantly influence infection risk.
Studies have also highlighted gender disparities in infection rates. In Colombia, the overall infection rate for M. ozzardi was 49%, with males (55%) showing higher prevalence than females (42%) [PMID:6986097]. Similarly, in Bayeux, Haiti, the infection prevalence was notably higher in older males (49%) compared to females (24%) [PMID:6969037]. These gender differences could be attributed to varying exposure patterns or biological susceptibilities.
The transmission dynamics are further complicated by the involvement of specific insect vectors. For instance, Simulium and Culicoides species have been implicated in the transmission of Mansonella species, with S. argentiscutum potentially playing a significant role in endemic areas [PMID:6756177]. This vector competence underscores the importance of vector control measures in managing the spread of mansonelliasis.
Overall, the epidemiological data emphasize the need for targeted public health interventions tailored to specific demographic and environmental contexts to effectively control the transmission and impact of mansonelliasis.
Clinical Presentation
The clinical presentation of mansonelliasis is often characterized by mild to moderate symptoms, reflecting the generally low parasitic load in infected individuals. Common manifestations include pruritus, rash, and inguinal adenopathy, which can significantly affect quality of life despite the absence of severe systemic symptoms [PMID:7951395]. Joint pains, while less frequent, are also reported and can contribute to chronic discomfort [PMID:1456469]. Occasional dizziness and, rarely, more severe conditions like elephantiasis (e.g., elephantoid scrotum) have been documented, indicating the potential for more pronounced manifestations in some cases [PMID:1456469].
The asymptomatic nature of adult worm locations, as observed in studies where worms were found in various abdominal sites without causing symptoms [PMID:3688309], suggests that the clinical symptoms are predominantly driven by the microfilariae rather than the adult worms themselves. The microfilariae, residing in superficial capillary vessels, likely induce localized inflammatory responses leading to symptoms such as itching and rash. The low parasitic load, with 88% of positive blood films containing fewer than 50 microfilariae and 71% of infected individuals having less than 10 microfilariae per 20 mm3 of blood, indicates that the disease burden is typically mild [PMID:6986097, PMID:6969037]. This mild presentation can sometimes lead to underdiagnosis or delayed recognition, particularly in endemic areas where multiple parasitic infections coexist.
In clinical practice, recognizing these subtle symptoms is crucial for early diagnosis and intervention. Given the variability in symptomatology, a thorough history and physical examination, complemented by appropriate diagnostic tests, are essential for identifying mansonelliasis, especially in endemic regions where the disease may be underreported.
Diagnosis
Diagnosing mansonelliasis requires a combination of clinical suspicion, serological tests, and parasitological examinations. Microfilariae detection remains a cornerstone of diagnosis, with peripheral blood smears being a common approach. However, the weak diurnal periodicity of M. perstans microfilariae, showing a peak around 0800 h, suggests that variations in sampling time have minimal impact on diagnostic outcomes [PMID:19107522]. This consistency in sampling timing simplifies diagnostic procedures in clinical settings.
Skin biopsies, particularly from areas like the shoulder, have proven highly effective for detecting M. streptocerca microfilariae, yielding the highest frequency of positive results [PMID:7951395]. Serological tests, while less specific, can provide additional support, especially in endemic regions. For instance, sera from individuals in Haiti endemic for M. ozzardi showed reactivity to various filarial and non-filarial antigens, with IgG reactivity being more pronounced than IgM [PMID:3513647]. This cross-reactivity underscores the importance of considering regional endemic patterns when interpreting serological results.
Combining blood smear analysis with skin biopsy techniques enhances diagnostic accuracy. Both methods—microfilariae detection in blood and skin—are viable and complementary, ensuring a comprehensive approach to confirming mansonelliasis. Clinicians should maintain a high index of suspicion, especially in endemic areas, and employ these diagnostic tools judiciously to achieve reliable results.
Management
The management of mansonelliasis primarily revolves around the use of anthelmintic medications, with ivermectin being a cornerstone treatment. Single-dose ivermectin has demonstrated significant efficacy in suppressing microfilariae, particularly for M. streptocerca, where a single oral dose of 150 μg/kg led to microfilaria-negative status in 46% of patients one year post-treatment [PMID:10479183]. This long-term suppression highlights the sustained benefit of ivermectin therapy.
Clinical trials have evaluated the efficacy of ivermectin alone versus its combination with albendazole. A randomized, double-blind trial found that while the combination therapy showed slightly better outcomes, the difference was not statistically significant [PMID:19081121]. Both treatments exhibited limited impact on reducing microfilarial intensities, with only one participant achieving sustained mf-negative status at follow-up points. These findings suggest that while ivermectin is effective, complete eradication may be challenging, necessitating repeated treatments and close monitoring.
In managing special populations, such as the elderly, tailored strategies are essential due to potential comorbidities and altered pharmacokinetics. Although specific geriatric data are limited, the asymptomatic nature of adult worm locations and the need for standardized sampling times in diagnosing M. perstans suggest that elderly patients may benefit from consistent diagnostic protocols [PMID:19107522]. Environmental and dietary factors specific to different regions can also influence treatment outcomes, warranting individualized approaches [PMID:19081121]. Given the coendemic presence of other filarial parasites, geriatric patients treated with ivermectin for other filarial infections may experience additional suppression of M. streptocerca microfilariae, highlighting the importance of comprehensive parasite management [PMID:10479183].
Overall, while current treatments offer significant relief, ongoing monitoring and potentially repeated therapeutic interventions are necessary to manage mansonelliasis effectively, especially in vulnerable populations.
Prognosis & Follow-up
The prognosis for individuals treated with anthelmintics like ivermectin is generally favorable, with notable reductions in microfilarial loads observed post-treatment. However, long-term efficacy remains a concern. Follow-up studies indicate that while there is sustained suppression of microfilariae, achieving sustained mf-negative status is uncommon. In a study evaluating ivermectin and albendazole combination therapy, only one participant remained mf-negative at both 6 and 12 months post-treatment [PMID:19081121]. Similarly, one-year follow-up after ivermectin treatment showed a significant drop in geometric mean microfilaria density to 0.7 mf/mg of skin, indicating sustained suppression but not complete eradication [PMID:10479183].
Regular follow-up is crucial to monitor microfilarial resurgence and manage potential relapses. Clinicians should schedule periodic assessments, particularly in endemic areas where reinfection is possible. Given the typically mild parasitic load and the challenges in achieving sustained mf-negative status, ongoing surveillance and repeated therapeutic interventions may be necessary to maintain control over the infection. This approach ensures that any resurgence of microfilariae is promptly addressed, thereby safeguarding patient health and preventing complications.
Key Recommendations
References
1 Ferreira MU, Crainey JL, Gobbi FG. The search for better treatment strategies for mansonellosis: an expert perspective. Expert opinion on pharmacotherapy 2023. link 2 Asio SM, Simonsen PE, Onapa AW. Analysis of the 24-h microfilarial periodicity of Mansonella perstans. Parasitology research 2009. link 3 Asio SM, Simonsen PE, Onapa AW. A randomised, double-blind field trial of ivermectin alone and in combination with albendazole for the treatment of Mansonella perstans infections in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009. link 4 Fischer P, Tukesiga E, Büttner DW. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin. The Journal of infectious diseases 1999. link 5 Anosike JC. Studies on filariasis in Bauchi State, Nigeria. V. The distribution and prevalence of mansonellosis with special reference to clinical signs. Applied parasitology 1994. link 6 Anosike JC, Onwuliri CO, Payne VK, Amuta EU, Akogun OB, Adeiyongo CM et al.. Observations on mansonellosis among the Ibos of Abia and Imo States, Nigeria. Angewandte Parasitologie 1992. link 7 Baird JK, Neafie RC, Lanoie L, Connor DH. Adult Mansonella perstans in the abdominal cavity in nine Africans. The American journal of tropical medicine and hygiene 1987. link 8 Katz SP, Raccurt CP, Lowrie RC, Boncy J, Leiva LM. Mansonella ozzardi in Haiti. IV. Evaluation of antibody reactivity to heterologous antigens. The American journal of tropical medicine and hygiene 1986. link 9 Tidwell MA, Tidwell MA. Development of Mansonella ozzardi in Simulium amazonicum, S. argentiscutum, and Culicoides insinuatus from Amazonas, Colombia. The American journal of tropical medicine and hygiene 1982. link 10 Lightner LK, Ewert A, Corredor A, Sabogal E. A parasitologic survey for Mansonella ozzardi in the Comisaría del Vaupés, Colombia. The American journal of tropical medicine and hygiene 1980. link 11 Raccurt C, Lowrie RC, McNeeley DF. Mansonella ozzardi in Haiti. I. Epidemiological survey. The American journal of tropical medicine and hygiene 1980. link 12 Nathan MB, Tikasingh ES, Nelson GS, Santiago A, Davies JB. The prevalence and distribution of Mansonella ozzardi in coastal north Trinidad, W.I. Transactions of the Royal Society of Tropical Medicine and Hygiene 1979. link90086-5)